{"id":16054,"date":"2016-08-22T17:45:24","date_gmt":"2016-08-22T15:45:24","guid":{"rendered":"http:\/\/mabdesign.fr\/maat-pharma\/"},"modified":"2016-08-22T17:45:24","modified_gmt":"2016-08-22T15:45:24","slug":"maat-pharma","status":"publish","type":"post","link":"https:\/\/mabdesign.fr\/en\/maat-pharma\/","title":{"rendered":"MaaT Pharma"},"content":{"rendered":"

MaaT Pharma<\/strong> est une start-up en biotechnologie cr\u00e9\u00e9e fin 2014 pour traiter les maladies graves li\u00e9es aux d\u00e9s\u00e9quilibres du microbiome intestinal. Elle d\u00e9veloppe la premi\u00e8re solution de traitement qui s\u2019appuie sur la microbioth\u00e9rapie autologue. MaaT Pharma envisage une premi\u00e8re application th\u00e9rapeutique \u00e0 destination des patients atteints de leuc\u00e9mie et d\u2019infections ost\u00e9oarticulaires, dont les traitements lourds favorisent les dysbioses. MaaT Pharma a pour ambition de devenir un leader dans la protection du microbiome et le traitement de ses dysbioses.<\/p>\n

En savoir plus<\/a><\/p>\n

 <\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

MaaT Pharma est une start-up en biotechnologie cr\u00e9\u00e9e fin 2014 pour traiter les maladies graves li\u00e9es aux d\u00e9s\u00e9quilibres du microbiome intestinal. Elle d\u00e9veloppe la premi\u00e8re solution de traitement qui s\u2019appuie sur la microbioth\u00e9rapie autologue. MaaT Pharma envisage une premi\u00e8re application th\u00e9rapeutique \u00e0 destination des patients atteints de leuc\u00e9mie et d\u2019infections ost\u00e9oarticulaires, dont les traitements lourds favorisent les dysbioses. MaaT Pharma a pour ambition de devenir un leader dans la protection du microbiome et le traitement de ses dysbioses.<\/p>\n","protected":false},"author":1,"featured_media":628,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[9,14],"tags":[],"class_list":["post-16054","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-actualites","category-nouveau-membre"],"yoast_head":"\nMaaT Pharma - MabDesign<\/title>\n<meta name=\"description\" content=\"MaaT Pharma est une start-up en biotechnologie cr\u00e9\u00e9e fin 2014 pour traiter les maladies graves li\u00e9es aux d\u00e9s\u00e9quilibres du microbiome intestinal. Elle d\u00e9veloppe la premi\u00e8re solution de traitement qui s\u2019appuie sur la microbioth\u00e9rapie autologue. MaaT Pharma envisage une premi\u00e8re application th\u00e9rapeutique \u00e0 destination des patients atteints de leuc\u00e9mie et d\u2019infections ost\u00e9oarticulaires, dont les traitements lourds favorisent les dysbioses. MaaT Pharma a pour ambition de devenir un leader dans la protection du microbiome et le traitement de ses dysbioses.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mabdesign.fr\/en\/maat-pharma\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MaaT Pharma - MabDesign\" \/>\n<meta property=\"og:description\" content=\"MaaT Pharma est une start-up en biotechnologie cr\u00e9\u00e9e fin 2014 pour traiter les maladies graves li\u00e9es aux d\u00e9s\u00e9quilibres du microbiome intestinal. Elle d\u00e9veloppe la premi\u00e8re solution de traitement qui s\u2019appuie sur la microbioth\u00e9rapie autologue. MaaT Pharma envisage une premi\u00e8re application th\u00e9rapeutique \u00e0 destination des patients atteints de leuc\u00e9mie et d\u2019infections ost\u00e9oarticulaires, dont les traitements lourds favorisent les dysbioses. MaaT Pharma a pour ambition de devenir un leader dans la protection du microbiome et le traitement de ses dysbioses.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mabdesign.fr\/en\/maat-pharma\/\" \/>\n<meta property=\"og:site_name\" content=\"MabDesign\" \/>\n<meta property=\"article:published_time\" content=\"2016-08-22T15:45:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/12\/Logo-MaaT-4e-version_small.png\" \/>\n\t<meta property=\"og:image:width\" content=\"157\" \/>\n\t<meta property=\"og:image:height\" content=\"158\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"alexis.mathias@kairios.fr\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:site\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"alexis.mathias@kairios.fr\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/mabdesign.fr\/en\/maat-pharma\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/maat-pharma\/\"},\"author\":{\"name\":\"alexis.mathias@kairios.fr\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135\"},\"headline\":\"MaaT Pharma\",\"datePublished\":\"2016-08-22T15:45:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/maat-pharma\/\"},\"wordCount\":96,\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/maat-pharma\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/12\/Logo-MaaT-4e-version_small.png\",\"articleSection\":[\"Actualit\u00e9s\",\"Nouveau membre\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/mabdesign.fr\/en\/maat-pharma\/\",\"url\":\"https:\/\/mabdesign.fr\/en\/maat-pharma\/\",\"name\":\"MaaT Pharma - MabDesign\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/maat-pharma\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/maat-pharma\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/12\/Logo-MaaT-4e-version_small.png\",\"datePublished\":\"2016-08-22T15:45:24+00:00\",\"description\":\"MaaT Pharma est une start-up en biotechnologie cr\u00e9\u00e9e fin 2014 pour traiter les maladies graves li\u00e9es aux d\u00e9s\u00e9quilibres du microbiome intestinal. Elle d\u00e9veloppe la premi\u00e8re solution de traitement qui s\u2019appuie sur la microbioth\u00e9rapie autologue. MaaT Pharma envisage une premi\u00e8re application th\u00e9rapeutique \u00e0 destination des patients atteints de leuc\u00e9mie et d\u2019infections ost\u00e9oarticulaires, dont les traitements lourds favorisent les dysbioses. MaaT Pharma a pour ambition de devenir un leader dans la protection du microbiome et le traitement de ses dysbioses.\",\"breadcrumb\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/maat-pharma\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/mabdesign.fr\/en\/maat-pharma\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/maat-pharma\/#primaryimage\",\"url\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/12\/Logo-MaaT-4e-version_small.png\",\"contentUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/12\/Logo-MaaT-4e-version_small.png\",\"width\":157,\"height\":158,\"caption\":\"MaaT Pharma\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/mabdesign.fr\/en\/maat-pharma\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/mabdesign.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MaaT Pharma\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"name\":\"Mabdesign\",\"description\":\"The Biotherapy Expert\",\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/mabdesign.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\",\"name\":\"Mabdesign\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"contentUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"width\":786,\"height\":233,\"caption\":\"Mabdesign\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/MabDesign_fr\",\"https:\/\/www.linkedin.com\/company\/mabdesign\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135\",\"name\":\"alexis.mathias@kairios.fr\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g\",\"caption\":\"alexis.mathias@kairios.fr\"},\"sameAs\":[\"http:\/\/mabdesign.fr\"],\"url\":\"https:\/\/mabdesign.fr\/en\/author\/amathiasigtcreative-fr\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MaaT Pharma - MabDesign","description":"MaaT Pharma est une start-up en biotechnologie cr\u00e9\u00e9e fin 2014 pour traiter les maladies graves li\u00e9es aux d\u00e9s\u00e9quilibres du microbiome intestinal. Elle d\u00e9veloppe la premi\u00e8re solution de traitement qui s\u2019appuie sur la microbioth\u00e9rapie autologue. MaaT Pharma envisage une premi\u00e8re application th\u00e9rapeutique \u00e0 destination des patients atteints de leuc\u00e9mie et d\u2019infections ost\u00e9oarticulaires, dont les traitements lourds favorisent les dysbioses. MaaT Pharma a pour ambition de devenir un leader dans la protection du microbiome et le traitement de ses dysbioses.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mabdesign.fr\/en\/maat-pharma\/","og_locale":"en_US","og_type":"article","og_title":"MaaT Pharma - MabDesign","og_description":"MaaT Pharma est une start-up en biotechnologie cr\u00e9\u00e9e fin 2014 pour traiter les maladies graves li\u00e9es aux d\u00e9s\u00e9quilibres du microbiome intestinal. Elle d\u00e9veloppe la premi\u00e8re solution de traitement qui s\u2019appuie sur la microbioth\u00e9rapie autologue. MaaT Pharma envisage une premi\u00e8re application th\u00e9rapeutique \u00e0 destination des patients atteints de leuc\u00e9mie et d\u2019infections ost\u00e9oarticulaires, dont les traitements lourds favorisent les dysbioses. MaaT Pharma a pour ambition de devenir un leader dans la protection du microbiome et le traitement de ses dysbioses.","og_url":"https:\/\/mabdesign.fr\/en\/maat-pharma\/","og_site_name":"MabDesign","article_published_time":"2016-08-22T15:45:24+00:00","og_image":[{"width":157,"height":158,"url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/12\/Logo-MaaT-4e-version_small.png","type":"image\/png"}],"author":"alexis.mathias@kairios.fr","twitter_card":"summary_large_image","twitter_creator":"@MabDesign_fr","twitter_site":"@MabDesign_fr","twitter_misc":{"Written by":"alexis.mathias@kairios.fr"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mabdesign.fr\/en\/maat-pharma\/#article","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/maat-pharma\/"},"author":{"name":"alexis.mathias@kairios.fr","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135"},"headline":"MaaT Pharma","datePublished":"2016-08-22T15:45:24+00:00","mainEntityOfPage":{"@id":"https:\/\/mabdesign.fr\/en\/maat-pharma\/"},"wordCount":96,"publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/maat-pharma\/#primaryimage"},"thumbnailUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/12\/Logo-MaaT-4e-version_small.png","articleSection":["Actualit\u00e9s","Nouveau membre"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/mabdesign.fr\/en\/maat-pharma\/","url":"https:\/\/mabdesign.fr\/en\/maat-pharma\/","name":"MaaT Pharma - MabDesign","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/mabdesign.fr\/en\/maat-pharma\/#primaryimage"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/maat-pharma\/#primaryimage"},"thumbnailUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/12\/Logo-MaaT-4e-version_small.png","datePublished":"2016-08-22T15:45:24+00:00","description":"MaaT Pharma est une start-up en biotechnologie cr\u00e9\u00e9e fin 2014 pour traiter les maladies graves li\u00e9es aux d\u00e9s\u00e9quilibres du microbiome intestinal. Elle d\u00e9veloppe la premi\u00e8re solution de traitement qui s\u2019appuie sur la microbioth\u00e9rapie autologue. MaaT Pharma envisage une premi\u00e8re application th\u00e9rapeutique \u00e0 destination des patients atteints de leuc\u00e9mie et d\u2019infections ost\u00e9oarticulaires, dont les traitements lourds favorisent les dysbioses. MaaT Pharma a pour ambition de devenir un leader dans la protection du microbiome et le traitement de ses dysbioses.","breadcrumb":{"@id":"https:\/\/mabdesign.fr\/en\/maat-pharma\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mabdesign.fr\/en\/maat-pharma\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/maat-pharma\/#primaryimage","url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/12\/Logo-MaaT-4e-version_small.png","contentUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/12\/Logo-MaaT-4e-version_small.png","width":157,"height":158,"caption":"MaaT Pharma"},{"@type":"BreadcrumbList","@id":"https:\/\/mabdesign.fr\/en\/maat-pharma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/mabdesign.fr\/en\/"},{"@type":"ListItem","position":2,"name":"MaaT Pharma"}]},{"@type":"WebSite","@id":"https:\/\/mabdesign.fr\/en\/#website","url":"https:\/\/mabdesign.fr\/en\/","name":"Mabdesign","description":"The Biotherapy Expert","publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mabdesign.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/mabdesign.fr\/en\/#organization","name":"Mabdesign","url":"https:\/\/mabdesign.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","contentUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","width":786,"height":233,"caption":"Mabdesign"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/MabDesign_fr","https:\/\/www.linkedin.com\/company\/mabdesign\/"]},{"@type":"Person","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/0a9d0510f7433c83f9e6974b2a9c0135","name":"alexis.mathias@kairios.fr","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9f0235d3b23103c20120728bbe93c75ab83e508d42949114def0b4d989a03f94?s=96&d=mm&r=g","caption":"alexis.mathias@kairios.fr"},"sameAs":["http:\/\/mabdesign.fr"],"url":"https:\/\/mabdesign.fr\/en\/author\/amathiasigtcreative-fr\/"}]}},"_links":{"self":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/16054","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/comments?post=16054"}],"version-history":[{"count":0,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/16054\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/media\/628"}],"wp:attachment":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/media?parent=16054"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/categories?post=16054"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/tags?post=16054"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}